A decrease in the angiotensin-converting enzyme (ACE)/angiotensin (Ang) II/Ang II type 1 receptor (AT1) axis of RAS provides protection from pathological cardiac hypertrophy and subsequent heart failure [64,65]. Here, ACE is linked to heart failure.